The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Associations between psychosocial risk factors and immune checkpoint inhibitor outcomes.
 
Heather Derry-Vick
Employment - Dechra (I); Elanco (I); Merck (I)
Stock and Other Ownership Interests - Merck (I)
 
Jacob Peter Zaemes
Consulting or Advisory Role - MJH Life Sciences
 
Jaeil Ahn
Consulting or Advisory Role - KeifeRx; KeifeRx
 
Lauren Pascual
No Relationships to Disclose
 
Brittany Sinclaire
No Relationships to Disclose
 
Shaked Lev-Ari
No Relationships to Disclose
 
Adil Alaoui
No Relationships to Disclose
 
Aishwarya Sridhar
No Relationships to Disclose
 
David Adams
No Relationships to Disclose
 
Alexandra Della Pia
No Relationships to Disclose
 
Andrew L Pecora
Employment - Celularity Inc; Cota Healthcare; Outcomes Matter Innovations (OMI); Regional Cancer Care Associates
Leadership - Celularity Inc; Cota Healthcare; Genetic testing cooperative (GTC); Regional Cancer Care Associates
Stock and Other Ownership Interests - Celularity Inc; Cota Healthcare; Genetic testing cooperative (GTC); Regional Cancer Care Associates
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst)
Patents, Royalties, Other Intellectual Property - Cd34 patents COTA patents
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Michael B. Atkins
Stock and Other Ownership Interests - Pyxis; Werewolf Pharma
Consulting or Advisory Role - Agenus; Asher Biotherapeutics; AstraZeneca; Aveo; Bristol-Myers Squibb; Cota Healthcare; Eisai; Ellipses Pharma; Exelixis; Fathom Biotechnology; Genentech; GlaxoSmithKline; Idera; Merck; Novartis; Oncorena; PACT Pharma; Pfizer; Pliant; Pyxis; Sanofi; Scholar Rock; Simcha Therapeutics; Surface Oncology; Takeda; Werewolf Pharma
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst)
 
Andrew Ip
Stock and Other Ownership Interests - Cota Healthcare; Merck (I)
Honoraria - MJH Life Sciences; MJH Life Sciences
Consulting or Advisory Role - Secura Bio; TG Therapeutics
Speakers' Bureau - AstraZeneca; Seagen
(OPTIONAL) Uncompensated Relationships - COTA; Genomic Testing Cooperative
 
Neil J. Shah
Honoraria - MedNet, LLC; MedNet, LLC; MJH Life Sciences
Consulting or Advisory Role - Exelixis; Graticule; Merck Sharp & Dohme Corp.
Research Funding - Aravive (Inst); Exelixis
Travel, Accommodations, Expenses - Merck